Scientific Research and Development

The Scientific Research and Development team at Virion is dedicated to advancing innovative T cell-based immunotherapies for cancer and chronic infections. This multidisciplinary group, comprised of experts in chemistry, medical science, and strategic leadership, collaborates on the discovery and optimization of novel therapies that integrate checkpoint blockade with antigenic stimulation, driving both preclinical and clinical development efforts. Their work is pivotal in shaping the future of targeted immunotherapy and improving patient outcomes.